From: Long-term outcomes of concomitant tricuspid valve repair in patients undergoing mitral valve surgery
Isolated MVS (N = 182) | MVS + TVR (N = 182) | P-value | |
---|---|---|---|
Procedure-related complications | |||
Postoperative mortality, % | 1.6 | 1.1 | 1.000 |
Wound infection, % | 3.3 | 3.3 | 1.000 |
Pericardial tamponade, % | 6.6 | 8.2 | 0.548 |
AV block grade III, % | 9.3 | 14.3 | 0.144 |
Pneumonia, % | 8.2 | 11.0 | 0.374 |
Pneumothorax, % | 0.5 | 0.5 | 1.000 |
Pleural effusion, % | 3.3 | 6.0 | 0.214 |
Atrial Fibrillation, % | 29.3 | 34.6 | 0.276 |
30-day complications | |||
Death, % | 7.7 | 5.5 | 0.398 |
CV death, % | 4.9 | 3.3 | 0.429 |
Non-CV death, % | 2.7 | 2.2 | 1.000 |
Stroke, % | 7.1 | 3.8 | 0.168 |
Acute renal failure, % | 12.2 | 12.6 | 0.889 |
Myocardial infarction, % | 0 | 0 | n.a. |
Pacemaker implantation, % | 8.8 | 16.0 | 0.037 |
Repeat MV surgery, % | 1.1 | 0.5 | 1.000 |